Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality-Reference-Cited by-同舟云学术

Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality

Published:2017-09-08 Issue:1 Volume:3 Page:
ISSN:2056-3973
Container-title:npj Aging and Mechanisms of Disease
language:en
Short-container-title:npj Aging Mech Dis

Author:

Sugizaki Taichi,Zhu Shunshun,Guo Ge,Matsumoto Akiko,Zhao Jiabin,Endo Motoyoshi,Horiguchi Haruki,Morinaga Jun,Tian Zhe,Kadomatsu Tsuyoshi,Miyata Keishi,Itoh Hiroshi,Oike Yuichi

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Ageing

Link

http://www.nature.com/articles/s41514-017-0012-0.pdf

Reference58 articles.

1. Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000).

2. Emerging Risk Factors Collaboration. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215–2222 (2010).

3. UK Prospective Diabetes Study (UKPDS). Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998a).

4. UK Prospective Diabetes Study (UKPDS). Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854–865 (1998b).

5. Holman, R. R. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes;International Journal of Molecular Sciences;2024-08-08

2. SGLT2 regulates immune-mediated senolysis;Nature Aging;2024-06-10

3. SGLT2i improves kidney senescence by down‐regulating the expression of LTBP2 in SAMP8 mice;Journal of Cellular and Molecular Medicine;2024-03

4. Cellular senescence and nanoparticle-based therapies: Current developments and perspectives;Nanotechnology Reviews;2024-01-01

5. Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu;Current Medicinal Chemistry;2024-01